Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Specialist System for Surgeons to Begin from June
May 13, 2002
- OTC NEWS IN BRIEF
May 13, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 13, 2002
- WORLD NEWS IN BRIEF
May 13, 2002
- President-elect Kobori to Follow Handa's Policy: MPC
May 13, 2002
- DIAGNOSTIC NEWS IN BRIEF
May 13, 2002
- SSP, Kirin Screen New LMW Compounds for Drug Discovery
May 13, 2002
- MEDICAL DEVICE NEWS IN BRIEF
May 13, 2002
- Sumitomo Agrees with GSK on Naratripan
May 13, 2002
- The South Africa Clinical Trial Mission
May 13, 2002
- Takeda Restructures Intellectual Property Department
May 13, 2002
- BULLETIN
May 13, 2002
- Loratadine Recommended to Be Approved as New Anti-allergic Drug
May 13, 2002
- Japanese, US, EU Patent Systems Need to Be Unified: Dr Fujino
May 13, 2002
- Abbott Aims at 20th Position in Japan: Mr Liepmann
May 13, 2002
- Debates on Healthcare Reform Start: Diet
May 13, 2002
- Wholesalers Should Take Firm Stance in Price Negotiations: FJPWA
May 13, 2002
- Original Makers to Take Tougher Stance against Patent Infringement
May 13, 2002
- BUSINESS NEWS IN BRIEF
May 13, 2002
- Number of Medical Accidents at Special Function Hospitals Totals over 15,000
May 13, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…